Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05715411

Assessment of Light Therapy in Insomnia Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Sleep disorders represent a major public health issue and the leader in these disorders is insomnia with 10 to 15% of subjects in the general population reporting symptoms of insomnia with a daytime impact. In addition to being very common, insomnia leads to an increase in morbidity and mortality and weighs on healthcare systems worldwide. Despite this public health context, insomnia is underdiagnosed and rarely treated. Hypnotics have proven efficacy but with a risk of dependence and pharmacotolerance which appears within a few weeks. Cognitive behavioral therapy (CBT) has a good level of evidence and is now a benchmark treatment for the management of insomnia. Unfortunately, not all patients adhere to or respond to these procedures, which cannot be implemented for many of them either. There is therefore a need to identify other alternative therapeutic strategies, and we believe that exposure to light is a promising treatment. In this perspective, it seems interesting to assess the effect of the propensity to fall asleep with an exposure to light therapy in patients suffering from insomnia. In order to be in optimal ecological conditions, we want to use a portable light therapy device which allows easy, acceptable and ambulatory exposure. If the lighttherapy is confirmed in insomnia under ecological conditions, this would make it possible to propose a new non-drug treatment, easy to access and on a large scale

Conditions

Interventions

TypeNameDescription
OTHERPlacebo with light therapy glassesPlacebo
OTHERlight therapy with light therapy glasseslight therapy

Timeline

Start date
2024-11-28
Primary completion
2026-06-01
Completion
2026-08-01
First posted
2023-02-08
Last updated
2025-08-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05715411. Inclusion in this directory is not an endorsement.